Industry: Technological Innovation Region: Italy Transaction Price: USD 1 million Transaction Method: Equity Financing
Description of Requirement:
An Italian company active in the surgical field has developed an innovative electrosurgical device aimed at the medical field in public and private facilities. The company is now ready to take innovation beyond national borders and is looking for technology partners in target countries who are willing to provide technical assistance under commercial agreements.
details:
1. Technical details
The Italian company based in northwestern Italy (Piedmont region) specializes in the design and manufacture of electronic medical devices, starting many years ago with the design of a highly innovative aesthetic medical and surgical system.
The combination of skills provided by a highly qualified team and management has allowed the company to develop a surgical technique based on the principle of converting air into an ideal conductor of plasma energy through an electronic process, resulting in an ionization process. Technology development and production are completely done within the company, and the market entry strategy is formulated by the company team.
This innovative device can greatly improve the efficiency of surgery and cosmetic results, and can completely protect the tissue. Surgical applications range from general to more specific, with equally accurate results. So far, the company has applied the technology on animal tissue, gaining a lot of experience with specific plasma surgical devices used in the veterinary community.
To expand overseas, the company is looking for foreign partners interested in promoting its equipment through commercial agreements and technical assistance. Potential partners should fully understand the local medical device market rules and technical skills related to the electrosurgery industry in order to provide technical assistance to local customers.
As part of its go-to-market strategy, the company selected priority target European countries for the initial commercial development of its device due to its potential size and market characteristics. However, given the company's ambitions to enter markets outside the EU within a few years, requests from other countries will also be assessed.
2. Advantages and Innovation
- Atmospheric ionization;
- low temperature plasma;
- Hypothermic surgery <50°C (no thermal damage) ;
- Fast recovery:
- Anti-bacterial and viral activity, meaning reduced risk of infection;
- direct and indirect activity against cancer cells;
- pain relief;
- There are no carcinogenic compounds in the smoke.